These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11185476)
1. Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non-small cell lung cancer. de Pas T; Catalano G; Pastorino U; de Braud F; Jereczek-Fossa B; Spaggiari L; Orecchi R Lung Cancer; 2000 Nov; 30(2):149-50. PubMed ID: 11185476 [No Abstract] [Full Text] [Related]
2. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
3. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497 [TBL] [Abstract][Full Text] [Related]
4. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer. Maas KW; El Sharouni SY; Smit EF; Schramel FM Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176 [TBL] [Abstract][Full Text] [Related]
5. Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma. Clark JI; Albain KS Cancer Treat Res; 2001; 105():149-70. PubMed ID: 11224986 [No Abstract] [Full Text] [Related]
14. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer. Uitterhoeve AL; Belderbos JS; Koolen MG; van der Vaart PJ; Rodrigus PT; Benraadt J; Koning CC; González González D; Bartelink H Eur J Cancer; 2000 Mar; 36(5):592-600. PubMed ID: 10738123 [TBL] [Abstract][Full Text] [Related]
15. Correspondence re L. J. Wirth et al., Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a phase I study. Clin Cancer Res 2003;9:1698-704. Cesario A; Margaritora S; Galetta D; Porziella V; Granone P; D'Angelillo RM; Trodella L; Cardaci V; Sterzi S; Russo P Clin Cancer Res; 2004 Apr; 10(8):2902-3; author reply 2904. PubMed ID: 15102699 [No Abstract] [Full Text] [Related]
16. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few. Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829 [No Abstract] [Full Text] [Related]
17. Unresectable stage III non-small-cell lung cancer: lessons and directions from clinical trials research. Green MR J Natl Cancer Inst; 1991 Mar; 83(6):382-3. PubMed ID: 1847976 [No Abstract] [Full Text] [Related]
18. Combined-modality treatment for stage IIIa (N2) non-small cell lung cancer: a National Cancer Institute Intergroup study. Ettinger DS Cancer Chemother Pharmacol; 1998; 42 Suppl():S71-4. PubMed ID: 9750033 [TBL] [Abstract][Full Text] [Related]
19. Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity study. Catalano G; Jereczek-Fossa BA; De Pas T; Leon ME; Cattani F; Spaggiari L; Veronesi G; de Braud F; Orecchia R Strahlenther Onkol; 2005 Jun; 181(6):363-71. PubMed ID: 15925978 [TBL] [Abstract][Full Text] [Related]
20. [Role of chemo(radio)theray prior to surgery for stage IIIa non-small cell lung carcinoma (localized non-resectable tumor)]. Smit EF; van Mourik JC; Slotman BJ; Postmus PE Ned Tijdschr Geneeskd; 1999 Oct; 143(40):1992-6. PubMed ID: 10535055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]